Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03163641
Other study ID # EYEGATE-033
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 5, 2018
Est. completion date November 8, 2018

Study information

Verified date January 2019
Source Eyegate Pharmaceuticals, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area.


Description:

This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area. Subjects will be assigned to one of three treatment arms on Day 0.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date November 8, 2018
Est. primary completion date October 31, 2018
Accepts healthy volunteers No
Gender All
Age group 22 Years to 50 Years
Eligibility Inclusion Criteria: - Able and willing to comply with the protocol Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Acuvue Oasys
Bandage Contact Lens
Ocular Bandage Gel
0.75% crosslinked HA

Locations

Country Name City State
United States Houston, Texas Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Eyegate Pharmaceuticals, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (1)

Durrie DS, Wolsey D, Thompson V, Assang C, Mann B, Wirostko B. Ability of a new crosslinked polymer ocular bandage gel to accelerate reepithelialization after photorefractive keratectomy. J Cataract Refract Surg. 2018 Mar;44(3):369-375. doi: 10.1016/j.jcr — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Time to corneal re-epithelization post PRK Time to corneal re-epithelization post PRK Day 3
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05331859 - Topical Insulin Versus Autologous Serum After Corneal Surgeries Phase 1
Completed NCT01441648 - Influence of Cosmetic Color Tinted Contact Lenses on the Ocular Surface N/A